 Monica Ertel
Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glaucoma | 8 | 2025 | 234 | 1.620 |
Why?
| | Phacoemulsification | 4 | 2025 | 122 | 1.030 |
Why?
| | Glaucoma Drainage Implants | 2 | 2021 | 46 | 0.820 |
Why?
| | Intraocular Pressure | 8 | 2025 | 305 | 0.810 |
Why?
| | Herpesvirus 1, Human | 3 | 2018 | 87 | 0.620 |
Why?
| | Cavernous Sinus Thrombosis | 1 | 2019 | 9 | 0.610 |
Why?
| | Cranial Sinuses | 1 | 2019 | 15 | 0.610 |
Why?
| | Sinus Thrombosis, Intracranial | 1 | 2019 | 21 | 0.600 |
Why?
| | Intracranial Arteriovenous Malformations | 1 | 2019 | 50 | 0.590 |
Why?
| | Intracranial Hypertension | 1 | 2019 | 38 | 0.590 |
Why?
| | Constriction, Pathologic | 1 | 2019 | 242 | 0.570 |
Why?
| | Stents | 2 | 2019 | 527 | 0.570 |
Why?
| | Glaucoma, Open-Angle | 3 | 2023 | 103 | 0.520 |
Why?
| | Virus Latency | 2 | 2018 | 82 | 0.510 |
Why?
| | Genome, Viral | 2 | 2018 | 143 | 0.500 |
Why?
| | Trabeculectomy | 2 | 2025 | 72 | 0.400 |
Why?
| | Virus Activation | 1 | 2012 | 88 | 0.380 |
Why?
| | Ocular Hypertension | 2 | 2022 | 67 | 0.350 |
Why?
| | Repressor Proteins | 1 | 2012 | 427 | 0.300 |
Why?
| | Epigenesis, Genetic | 1 | 2012 | 657 | 0.280 |
Why?
| | CCCTC-Binding Factor | 2 | 2018 | 14 | 0.240 |
Why?
| | Pilocarpine | 1 | 2025 | 15 | 0.230 |
Why?
| | Tonometry, Ocular | 2 | 2021 | 95 | 0.220 |
Why?
| | Iritis | 1 | 2023 | 2 | 0.200 |
Why?
| | Contact Lenses | 1 | 2022 | 9 | 0.190 |
Why?
| | Uveitis | 1 | 2022 | 134 | 0.180 |
Why?
| | Cataract | 1 | 2023 | 213 | 0.170 |
Why?
| | Herpes Simplex | 2 | 2018 | 95 | 0.170 |
Why?
| | Iris | 1 | 2019 | 19 | 0.160 |
Why?
| | Eye Foreign Bodies | 1 | 2019 | 25 | 0.160 |
Why?
| | Insulator Elements | 1 | 2018 | 2 | 0.150 |
Why?
| | Postoperative Complications | 2 | 2021 | 2639 | 0.140 |
Why?
| | Nucleotide Motifs | 1 | 2018 | 35 | 0.140 |
Why?
| | Thrombolytic Therapy | 1 | 2019 | 141 | 0.140 |
Why?
| | Transduction, Genetic | 1 | 2016 | 126 | 0.120 |
Why?
| | Dependovirus | 1 | 2016 | 68 | 0.120 |
Why?
| | DNA, Viral | 1 | 2018 | 363 | 0.120 |
Why?
| | Sensory Receptor Cells | 1 | 2016 | 98 | 0.120 |
Why?
| | Genetic Vectors | 1 | 2016 | 317 | 0.120 |
Why?
| | Mice, Inbred BALB C | 2 | 2018 | 1269 | 0.110 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2012 | 138 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 346 | 0.090 |
Why?
| | DNA Primers | 1 | 2012 | 514 | 0.090 |
Why?
| | Analysis of Variance | 1 | 2012 | 1316 | 0.080 |
Why?
| | Docosahexaenoic Acids | 1 | 2010 | 84 | 0.080 |
Why?
| | Humans | 11 | 2025 | 136768 | 0.080 |
Why?
| | Choroidal Neovascularization | 1 | 2010 | 56 | 0.080 |
Why?
| | Retrospective Studies | 5 | 2025 | 15504 | 0.070 |
Why?
| | Miotics | 1 | 2025 | 6 | 0.060 |
Why?
| | Muscarinic Agonists | 1 | 2025 | 16 | 0.060 |
Why?
| | Mice | 4 | 2018 | 17757 | 0.060 |
Why?
| | Postoperative Period | 1 | 2025 | 342 | 0.050 |
Why?
| | Loteprednol Etabonate | 1 | 2023 | 6 | 0.050 |
Why?
| | Postoperative Care | 1 | 2025 | 261 | 0.050 |
Why?
| | Acetazolamide | 1 | 2023 | 26 | 0.050 |
Why?
| | Triamcinolone Acetonide | 1 | 2023 | 28 | 0.050 |
Why?
| | Laser Coagulation | 1 | 2023 | 68 | 0.050 |
Why?
| | Prosthesis Fitting | 1 | 2022 | 15 | 0.050 |
Why?
| | Sclera | 1 | 2022 | 36 | 0.050 |
Why?
| | Communication Barriers | 1 | 2023 | 104 | 0.050 |
Why?
| | Manometry | 1 | 2021 | 95 | 0.040 |
Why?
| | Visual Acuity | 1 | 2022 | 348 | 0.040 |
Why?
| | Animals | 4 | 2018 | 36847 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2025 | 10744 | 0.040 |
Why?
| | Circadian Rhythm | 1 | 2023 | 468 | 0.040 |
Why?
| | Female | 4 | 2025 | 72796 | 0.030 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2018 | 67 | 0.030 |
Why?
| | Parvoviridae Infections | 1 | 2016 | 12 | 0.030 |
Why?
| | Ecosystem | 1 | 2022 | 594 | 0.030 |
Why?
| | Trigeminal Ganglion | 1 | 2016 | 25 | 0.030 |
Why?
| | Sleep | 1 | 2023 | 753 | 0.030 |
Why?
| | Ganglia, Spinal | 1 | 2016 | 77 | 0.030 |
Why?
| | Eye | 1 | 2016 | 108 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2025 | 5106 | 0.030 |
Why?
| | Foot | 1 | 2016 | 97 | 0.030 |
Why?
| | Coinfection | 1 | 2016 | 137 | 0.030 |
Why?
| | Rabbits | 1 | 2016 | 792 | 0.030 |
Why?
| | Prevalence | 1 | 2022 | 2711 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3264 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2025 | 7585 | 0.020 |
Why?
| | Aged | 2 | 2025 | 23794 | 0.020 |
Why?
| | Middle Aged | 2 | 2025 | 33228 | 0.020 |
Why?
| | Fluorescein | 1 | 2010 | 25 | 0.020 |
Why?
| | Fundus Oculi | 1 | 2010 | 65 | 0.020 |
Why?
| | Cell Size | 1 | 2010 | 91 | 0.020 |
Why?
| | Lasers | 1 | 2010 | 130 | 0.020 |
Why?
| | Fluorescein Angiography | 1 | 2010 | 150 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2010 | 324 | 0.020 |
Why?
| | Prospective Studies | 1 | 2021 | 7572 | 0.020 |
Why?
| | Male | 3 | 2025 | 67311 | 0.020 |
Why?
| | Retina | 1 | 2010 | 298 | 0.020 |
Why?
| | Endothelial Cells | 1 | 2010 | 778 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2010 | 2475 | 0.010 |
Why?
| | Adult | 1 | 2025 | 37630 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2010 | 5749 | 0.010 |
Why?
|
|
Ertel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|